RP-L401
RP-L401-0120
Phase 1 mab terminated
Quick answer
RP-L401 for Infantile Malignant Osteopetrosis is a Phase 1 program (mab) at Rocket Pharmaceuticals B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Rocket Pharmaceuticals B.V.
- Indication
- Infantile Malignant Osteopetrosis
- Phase
- Phase 1
- Modality
- mab
- Status
- terminated